Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 781-800
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Christine Borowski Principal at Access Industries | New York City, United States | Private equityVenture capital | ConsumerHealthcare | ||
 Hayal Koc Investor & LP at Emmeline Ventures | London, United Kingdom | AcceleratorVenture capital | AIClimate | ||
 Oscar Ramos Managing General Partner at Orbit Ventures | Shanghai, China | AcceleratorVenture capital | AIClimate | ||
 Jim Momtazee Managing Partner at Patient Square Capital | Menlo Park, United States | Private equityVenture capital | FinTechHardware | ||
 Richard Svinkin AI Product Mgt., Angel Investor at Astellas Pharma | New York, United States | Corporate VCVenture capital | AICommerce | ||
 Sarit Steinberg Partner at Israel Biotech Fund | Israel | Corporate VCVenture capital | CommerceConsumer | ||
 Bernard Cooney Senior Partner at Flagship Pioneering | Cambridge, United States | AcceleratorVenture capital | AIClimate | ||
 Tony Kulesa Co-Founder at Petri | Boston, United States | Venture capital | AIFinTech | ||
 Benjamin Lund Partner at Soleus Capital Management | New York, United States | Private equityVenture debt | Healthcare | ||
 Hannes H. Director, Life Science Investments & Data Science at Thiel Capital | Los Angeles, United States | Family OfficeVenture capital | AIHardware | ||
 Lou Tartaglia Managing Partner and Co-Founder at Cure Ventures | Boston, United States | AcceleratorVenture capital | Healthcare | ||
 Andrew Kaplan Board Observer at Tanabe Pharma America | Boston, United States | Corporate VCPrivate equity | AICommerce | ||
 Avantika Daing Founding Partner at Plum Alley | New York, United States | Syndicate / Angel groupVenture capital | AIClimate | ||
 Ian Howes CFO and Managing Director at Accelerator Life Science Partners | Chapel Hill, United States | Accelerator | Healthcare | ||
 Max Arias Investor at Willett Advisors | New York, United States | Family Office | AIFinTech | ||
 Lesley Sutherland Angel Investor at Mint Venture Partners | United Kingdom | AcceleratorSyndicate / Angel group | AIConsumer | ||
 Wangee Cho Director at Atinum Investment | Gangnam District, South Korea | Venture capital | AICommerce | ||
 Yao Ho Managing Director at LYFE Capital | Menlo Park, United States | Private equity | HardwareHealthcare | ||
 Tyler Aveni Investor at Goodman | Jing'an District, China | Corporate VC | ConsumerHealthcare | ||
 Ben Phillis Head of Investment Fund at UniQuest | Brisbane, Australia | AcceleratorCorporate VC | HardwareHealthcare |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal